HealthCap
Venture capital
RollingLast verified 11 Nov 2026
HealthCap is a venture capital firm and company creator investing in life sciences, specifically emerging therapeutics for rare diseases, cancers, and genetic conditions.
1 deal in the last 24 months, latest 14 Apr 2026. Derived from its deals in the news.
Key facts
- Stages
- Series C+
- Sectors
- Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- Sweden
- Timing
- Rolling applications
- Focus
- life science; targeted therapies; rare diseases; cancers; genetic diseases; emerging therapeutics
- How to apply
- Apply route unknown
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Adcendo ApS | Series C+ | Biotech & pharma, Healthtech | €67.2M | participant | 14 Apr 2026 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Venture Capital for Breakthrough Therapies
https://www.healthcap.eu/ - Sectors
HealthCap is a life science investor and company creator.
https://www.healthcap.eu/
Status history
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at HealthCap? Claim this profile to confirm what you invest in.